Search of: Open Studies | United States, Virginia - List Results

Rank

Status

Study

Recruiting

Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer

Condition:	Breast Cancer
Interventions:	Drug: clodronate disodium; Drug: ibandronate sodium; Drug: zoledronic acid

Recruiting

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery

Condition:	Lung Cancer
Interventions:	Drug: bevacizumab; Drug: carboplatin; Drug: cisplatin; Drug: docetaxel; Drug: gemcitabine hydrochloride; Drug: paclitaxel; Drug: vinorelbine ditartrate

Recruiting

A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small Cell Lung Cancer (ARIES)

Conditions:	Colorectal Cancer; Non-Small Cell Lung Cancer
Intervention:

Recruiting

Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer

Condition:	Breast Cancer
Interventions:	Drug: bevacizumab; Drug: cyclophosphamide; Drug: paclitaxel; Drug: pegylated liposomal doxorubicin hydrochloride; Drug: placebo

Recruiting

A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome

Condition:	Coronary Heart Disease
Interventions:	Drug: RO4607381; Drug: Placebo; Drug: Evidence-based medical care for Acute Coronary Syndrome

Recruiting

Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen

Conditions:	Arthritis, Rheumatoid; Osteoarthritis
Interventions:	Drug: celecoxib; Drug: Ibuprofen; Drug: Naproxen

Recruiting

Randomized Phase 3b Study in Previously Untreated Multiple Myeloma Patients: VELCADE,Thalidomide, and Dexamethasone Versus VELCADE and Dexamethasone Versus VELCADE, Melphalan, and Prednisone

Condition:	Multiple Myeloma
Interventions:	Drug: bortezomib, thalidomide, and dexamethasone (VTD); Drug: bortezomib and dexamethasone (VD); Drug: bortezomib, melphalan and prednisone (VMP)

Recruiting

Combination Chemotherapy in Treating Women With Breast Cancer

Condition:	Breast Cancer
Interventions:	Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: paclitaxel

Recruiting

Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)

Condition:	Hyperphosphatemia
Intervention:

Recruiting

Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

Condition:	Leukemia
Interventions:	Drug: cyclophosphamide; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: dexamethasone; Drug: doxorubicin hydrochloride; Drug: leucovorin calcium; Drug: mercaptopurine; Drug: methotrexate; Drug: pegaspargase; Drug: prednisone; Drug: thioguanine; Drug: vincristine sulfate; Procedure: radiation therapy

Recruiting

RADIANT: A Study of Tarceva After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) - Positive Tumors

Condition:	Non-Small Cell Lung Cancer
Interventions:	Drug: Tarceva; Drug: Placebo

Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine ER in Patients With Overactive Bladder.

Condition:	Overactive Bladder
Interventions:	Drug: Tolterodine ER; Drug: Placebo; Drug: Fesoterodine

Recruiting

The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-Term Safety and Tolerability of TMC125 Combined With Other Antiretroviral Drugs.

Condition:	HIV-1
Intervention:	Drug: TMC125

Recruiting

Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy

Condition:	Prostate Cancer
Intervention:	Drug: dutasteride

Recruiting

Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer

Condition:	Colorectal Cancer
Interventions:	Drug: bevacizumab; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Procedure: observation

Recruiting

Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Condition:	Head and Neck Cancer
Interventions:	Drug: cetuximab; Drug: cisplatin

Recruiting

Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma

Condition:	Locally Advanced and/or Metastatic Renal Cell Carcinoma
Intervention:	Drug: Pazopanib (drug) sunitinib (drug)

Recruiting

Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer

Conditions:	Ovarian Cancer; Peritoneal Cavity Cancer
Interventions:	Drug: paclitaxel; Drug: paclitaxel poliglumex; Procedure: observation

Recruiting

Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Conditions:	Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
Interventions:	Drug: bevacizumab; Drug: carboplatin; Drug: paclitaxel; Drug: placebo

Recruiting

Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC)

Condition:	Carcinoma, Renal Cell
Interventions:	Drug: Sunitinib Malate Continuous Daily Dosing; Drug: Sunitinib Malate Schedule 4/2